← Back to Screener
Cardio Diagnostics Holdings Inc. Common stock (CDIO)
Price$1.97
Favorite Metrics
Price vs S&P 500 (26W)-60.31%
Price vs S&P 500 (4W)-21.72%
Market Capitalization$5.95M
All Metrics
Book Value / Share (Quarterly)$3.82
P/TBV (Annual)0.81x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-3.37
Price vs S&P 500 (YTD)-29.97%
Net Profit Margin (TTM)-43788.21%
EPS (TTM)$-3.72
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-3.72
EPS (Annual)$-3.71
ROI (Annual)-89.71%
Cash / Share (Quarterly)$2.80
Revenue Growth QoQ (YoY)-21.06%
ROA (Last FY)-83.67%
Revenue Growth TTM (YoY)-57.47%
EBITD / Share (TTM)$-3.67
ROE (5Y Avg)-126.08%
Operating Margin (TTM)-43693.13%
Cash Flow / Share (Annual)$-3.37
P/B Ratio0.85x
P/B Ratio (Quarterly)0.71x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)74.64x
Net Interest Coverage (TTM)-460.19x
ROA (TTM)-66.25%
EPS Incl Extra (Annual)$-3.71
Current Ratio (Annual)9.79x
Quick Ratio (Quarterly)8.46x
3-Month Avg Trading Volume2.77M
52-Week Price Return-82.09%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.34
P/S Ratio (Annual)401.11x
Asset Turnover (Annual)0.00x
52-Week High$17.40
EPS Excl Extra (Annual)$-3.71
CapEx CAGR (5Y)69.47%
26-Week Price Return-51.57%
Quick Ratio (Annual)8.46x
13-Week Price Return10.44%
Total Debt / Equity (Annual)0.04x
Current Ratio (Quarterly)9.79x
Enterprise Value$1.108
Asset Turnover (TTM)0.00x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-43817.73%
Cash / Share (Annual)$2.80
3-Month Return Std Dev250.00%
Net Income / Employee (TTM)$-0
ROE (Last FY)-93.19%
Net Interest Coverage (Annual)-460.52x
EPS Basic Excl Extra (Annual)$-3.71
Receivables Turnover (TTM)1.11x
Total Debt / Equity (Quarterly)0.04x
EPS Incl Extra (TTM)$-3.72
Receivables Turnover (Annual)1.11x
ROI (TTM)-70.70%
P/S Ratio (TTM)400.84x
Revenue / Share (Annual)$0.01
Tangible BV / Share (Annual)$3.34
Price vs S&P 500 (52W)-117.18%
Year-to-Date Return-25.83%
5-Day Price Return6.91%
EPS Normalized (Annual)$-3.71
ROA (5Y Avg)-96.26%
Net Profit Margin (Annual)-43817.73%
Month-to-Date Return3.08%
EBITD / Share (Annual)$-3.66
Operating Margin (Annual)-43722.66%
ROI (5Y Avg)-114.91%
EPS Basic Excl Extra (TTM)$-3.72
P/TBV (Quarterly)0.81x
P/B Ratio (Annual)0.71x
Pretax Margin (TTM)-43788.21%
Book Value / Share (Annual)$3.82
Price vs S&P 500 (13W)7.57%
Beta2.50x
Revenue / Share (TTM)$0.01
ROE (TTM)-71.75%
52-Week Low$0.97
Analyst Recommendations
Jun 2025
Jul 2025
Aug 2025
Oct 2025
4.14
4.14
4.14
4.14
Industry Peers — In Vitro Diagnostics(17)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CDIOCardio Diagnostics Holdings Inc. Common stock | 400.84x | -57.47% | — | — | $1.97 |
IDXXIdexx Laboratories Inc | 10.72x | 10.42% | 61.80% | 14.28% | $583.06 |
LNTHLantheus Holdings, Inc | 3.55x | 0.50% | 61.10% | 40.71% | $83.97 |
NNNNAnbio Biotechnology Class A Ordinary Shares | 295.25x | -5.72% | 89.00% | — | $26.98 |
CLDXCelldex Therapeutics, Inc | 1744.87x | -77.98% | 17.65% | — | $34.38 |
NEOGNeogen Corp | 2.39x | -3.91% | 45.20% | — | $9.63 |
NTLAIntellia Therapeutics, Inc | 26.55x | 16.92% | — | — | $15.21 |
QDELQuidelOrtho Corporation Common Stock | 0.32x | -1.89% | 46.67% | — | $12.89 |
MYGNMyriad Genetics Inc | 0.59x | -1.56% | 69.93% | — | $5.14 |
ACHVAchieve Life Sciences, Inc. | 12.70x | -89.25% | — | — | $4.25 |
TKNOAlpha Teknova, Inc. Common Stock | 3.87x | 7.35% | 33.17% | — | $2.91 |
About
Cardio Diagnostics Holdings Inc develops AI-powered epigenetics-based clinical tests for coronary heart disease risk assessment, detection, and management. The company's diagnostic platform combines epigenetic and genetic biomarkers to provide personalized clinical insights for healthcare providers. Its three main solutions—Epi+Gen CHD, PrecisionCHD, and Actionable Clinical Intelligence—enable better identification and management of patients at risk for coronary events.